BLOG

Part 4: Macro-Insights for Industry

Part 4: Macro-Insights for Industry

Part 4: Macro-Insights for Industry  5 Macro-Insights for Industry  The FDA Proposed Rules are poised to have sweeping and substantial impact across the life sciences supply chain. Here are 5 key considerations for industry: 1. Timeline  With the comment period...

read more
Drug Price Transparency
The Increasing Trend of Drug Price Transparency

Drug Pricing Transparency Fight Rages On

Even as the COVID-19 pandemic disrupts day-to-day life, drug pricing transparency rages on between consumer groups, regulators, and industry. Regulators are now having to resort to assessing significant fines to increase compliance.

read more
2020 Update: Continuing Pressure on Drug Manufacturers

2020 Update: Continuing Pressure on Drug Manufacturers

With the developments around COVID-19, the drug manufacturers that working on a cure for the virus have been praised as (potential) saviors across the globe. This is a stark change to how they have regarded over the last few years – drug manufacturers have faced significant scrutiny due to a variety of issues including the opioid epidemic, generic price-fixing and price increases.

read more

Email Newsletter